| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
|
J Neurol Neurosurg Psychiatry
|
1986
|
1.84
|
|
2
|
Dopamine visualized in the basal ganglia of living man.
|
Nature
|
1983
|
1.82
|
|
3
|
Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea.
|
Mov Disord
|
1987
|
1.18
|
|
4
|
Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography.
|
Can J Neurol Sci
|
1984
|
1.01
|
|
5
|
Striatal dopamine distribution in parkinsonian patients during life.
|
J Neurol Sci
|
1985
|
1.01
|
|
6
|
The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study.
|
Circulation
|
2000
|
1.00
|
|
7
|
Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.
|
J Nucl Med
|
1984
|
0.99
|
|
8
|
Striatal dopamine metabolism in living monkeys examined by positron emission tomography.
|
Brain Res
|
1983
|
0.96
|
|
9
|
[18F]fluoro-dopa, an analogue of dopa, and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine.
|
Proc Natl Acad Sci U S A
|
1978
|
0.92
|
|
10
|
Intracerebral dopamine metabolism studied by a novel radioisotope technique.
|
J Pharm Pharmacol
|
1976
|
0.90
|
|
11
|
Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.
|
J Neurochem
|
1987
|
0.87
|
|
12
|
Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
|
Arch Gen Psychiatry
|
1988
|
0.86
|
|
13
|
Regional cerebral glucose metabolism of newborn infants measured by positron emission tomography.
|
Dev Med Child Neurol
|
1983
|
0.84
|
|
14
|
64Cu labelling of hematoporphyrin derivative for non-invasive in-vivo measurements of tumour uptake.
|
Prog Clin Biol Res
|
1984
|
0.84
|
|
15
|
A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum.
|
Can J Neurol Sci
|
1987
|
0.84
|
|
16
|
Blood-brain barrier transport and cerebral utilization of dopa in living monkeys.
|
Am J Physiol
|
1980
|
0.83
|
|
17
|
The preparation of ( 18 F)5-fluoro-DOPA with reactor-produced fluorine-18.
|
Int J Appl Radiat Isot
|
1973
|
0.83
|
|
18
|
(18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.
|
Experientia
|
1975
|
0.82
|
|
19
|
Radiofluorination with xenon difluoride: a new high yield synthesis of [18F]2-fluro-2-deoxy-D-glucose.
|
Int J Appl Radiat Isot
|
1983
|
0.82
|
|
20
|
The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
|
J Cereb Blood Flow Metab
|
1994
|
0.81
|
|
21
|
Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans.
|
Heart
|
1996
|
0.81
|
|
22
|
Estimation of the radiation dose in man due to 6-[18F]fluoro-L-dopa.
|
J Nucl Med
|
1985
|
0.81
|
|
23
|
Regional cerebral blood flow in man manipulated by direct vagal stimulation.
|
Pacing Clin Electrophysiol
|
1992
|
0.81
|
|
24
|
A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
|
Mov Disord
|
1995
|
0.80
|
|
25
|
Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
|
Psychiatry Res
|
1989
|
0.79
|
|
26
|
Electrophilic 18F from a Siemens 11 MeV proton-only cyclotron.
|
Nucl Med Biol
|
1995
|
0.78
|
|
27
|
Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease.
|
J Neurol Sci
|
1984
|
0.78
|
|
28
|
Effects of fluoro-dopamines on dopamine receptors (D1, D2, D3, sites).
|
Biochem Pharmacol
|
1981
|
0.78
|
|
29
|
Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
|
Neuropediatrics
|
1988
|
0.77
|
|
30
|
Phenol ionization in dopa determines the site of methylation by catechol-O-methyltransferase.
|
Mol Pharmacol
|
1981
|
0.77
|
|
31
|
Pre-synaptic and post-synaptic dopaminergic system in human brain.
|
Lancet
|
1984
|
0.77
|
|
32
|
Direct radiofluorination of dopamine: 18F-labeled 6-fluorodopamine for imaging cardiac sympathetic innervation in humans using positron emission tomography.
|
Nucl Med Biol
|
1996
|
0.77
|
|
33
|
Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
|
Adv Neurol
|
1987
|
0.77
|
|
34
|
High yield synthesis of 6-[18F]fluoro-L-dopa.
|
J Nucl Med
|
1986
|
0.77
|
|
35
|
Dopamine D2 receptors quantified in vivo in human narcolepsy.
|
Biol Psychiatry
|
1997
|
0.76
|
|
36
|
[18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.
|
Int J Rad Appl Instrum A
|
1986
|
0.75
|
|
37
|
A positron emission tomograph to study brain metabolism in man.
|
J Can Assoc Radiol
|
1982
|
0.75
|
|
38
|
Noninvasive measurement of lung carbon-11-serotonin extraction in man.
|
J Nucl Med
|
1991
|
0.75
|
|
39
|
Synthesis of 3,4-dihydroxy-5-fluoro-DL-phenylalanine and 3,4-dihydroxy-5-( 18 F)fluoro-DL-phenylalanine.
|
J Med Chem
|
1973
|
0.75
|
|
40
|
Studies of HPD and radiolabelled HPD in-vivo and in-vitro.
|
Adv Exp Med Biol
|
1985
|
0.75
|
|
41
|
Positron tomography in dystonia.
|
Adv Neurol
|
1988
|
0.75
|
|
42
|
Synthesis of 2-iodo- and 2-phenyl-[11C]melatonin: potential PET tracers for melatonin binding sites.
|
Appl Radiat Isot
|
1998
|
0.75
|
|
43
|
Why do Tc-99m chelates work for cholescintigraphy?
|
Eur J Nucl Med
|
1976
|
0.75
|
|
44
|
Intracerebral dopamine metabolism measured with [18F]fluoro dopa.
|
Acta Neurol Scand Suppl
|
1977
|
0.75
|